æ
å ±
ã¬ãã¥ãŒã®ãŸãšã
ãã©ãŒã·ãŒãºã³ãºã»ã¢ã€ã©ã³ãã»ãªãŸãŒãã¯ããã¬ã³ããªãŒãªã¹ã¿ãããæåŸ
以äžã®ãµãŒãã¹ãæäŸããŠããããçŽ æŽãããæ»åšå
ãšããŠé«ãè©äŸ¡ãåŸãŠããŸããããã«ã§ã¯çŸå³ããæçãšçŽ æŽããããµãŒãã¹ãæäŸããŠãããç¹ã«ããŒã®ã¹ã¿ããã¯è¿
éã§åªãããµãŒãã¹ã§è©äŸ¡ãããŠããŸããå€ãã®å®¿æ³å®¢ãã¹ã¿ããã®å¯Ÿå¿ã®è¯ãã«æéãåããæè¿çã§ãŸãã§å®¶ã«ãããã®ãããªæ°åã«ãããŠããããšè³è³ããŠããŸããã¢ã¡ããã£ã«é¢ããæ
å ±äžè¶³ãããŒãã³ããŒã®ç¡ç€Œãªçºèšãªã©ãæ°ã«ãªãç¹ããã£ãããã§ãããã»ãšãã©ã®å®¿æ³å®¢ã¯ãæ»åšã楜ãããã®ã«ããããã®ããã«ã®ã¹ã¿ããã®ç®èº«çãªå§¿å¢ã«éåžžã«æéãåããŠããŸããããã§ãã¯ã¢ãŠãã®éãã¹ã¿ãããæ»åšã«ã€ããŠå°ããªãã£ããšããç©è¶³ããªããæããã²ã¹ããããŸããããå
šäœçã«ãããã«ã¯å®¿æ³å®¢ããé«ãè©äŸ¡ãåŸãŠãããä»ã®äººã«ã匷ããå§ãã§ããå Žæã§ãã è¿ãã«ããã«ã2è»ãããŸã
$59 ãã
æ
å ±
ã¬ãã¥ãŒã®ãŸãšã
å
šäœçã«ããã€ã¢ã³ãã»ãã€ã»ãŠã£ã³ãã ã»ã¢ã€ã¢ã³ããŠã³ãã³ã¯ãå°èŠæš¡ãªãããæå
¥ãã®è¡ãå±ããããŒã«ãšãããã¿ããšãªã¢ããããå¿«é©ãªæ»åšãæäŸããŠããŸããããŒã«ãééãããŠããããæ°Žã®äžã«è«ãããããšããã¬ãã£ããªçµéšãããã²ã¹ããããŸããããã»ãšãã©ã®ã²ã¹ãã¯ã¢ã¡ããã£ã楜ããã§ããŸãããæž
æœãã«é¢ããŠäžæºãæã€äººãããŸããããããã«ã¯é
åçã§æè¿æ¹è£
ããããšæãã人ãããŸãããCOVID-19ã®åœ±é¿ã§ãæé£ãšããŒã«ãžã®ã¢ã¯ã»ã¹ã¯å¶éãããŠããŸããããå®¢å®€ã«æé£çšã®ããŒãã«ã眮ãããšãææ¡ããã²ã¹ããããŸãããäºçŽåã«ããŒã«ã®ç¶æ³ã確èªããããšããå§ãããŸãã ã¢ããªã§ãã£ãšãåŸã«